Viatris stock trades at 17.24 euros ahead of results

Published on 11/05/2026 at 13:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The drugmaker is due to report its third quarter on Thursday. Investors will focus on the outlook for branded, generic and biosimilar medicines.

Results Set the Next Catalyst

Viatris plans to release third-quarter results on Thursday, November 5.
The update will give investors a fresh read on the drugmaker's outlook.

Viatris, US92556V1061, Illustration mit AI erstellt.

Viatris stock traded at 17.24 euros on Lang & Schwarz at 13:38 CET on Thursday, November 5. The quote comes as investors await the company's scheduled third-quarter results release.

Results Set the Next Catalyst

Viatris plans to publish its third-quarter update on Thursday. The report is expected to give investors a fresh read on the drugmaker's outlook across branded, generic and biosimilar medicines.

Trading Context

The latest euro quote gives investors an intraday reference ahead of the scheduled company update. The earnings release, rather than the share price alone, is the next stated event for the stock.

For the real-time quote of Viatris stock, investors can follow the latest trading indication.